Opportunity ID: 293783

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-17-283
Funding Opportunity Title: Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 12, 2017
Last Updated Date:
Original Closing Date for Applications: Sep 07, 2020
Current Closing Date for Applications: Sep 07, 2020
Archive Date: Oct 13, 2020
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
County governments
Public and State controlled institutions of higher education
State governments
Special district governments
Private institutions of higher education
For profit organizations other than small businesses
City or township governments
Native American tribal governments (Federally recognized)
Small businesses
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-17-283.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-D Use for due dates on or before January 24, 2018 PKG00232496 Aug 07, 2017 Jan 24, 2018 View
FORMS-E Use for due dates on or before May 24, 2020 PKG00235983 Nov 09, 2017 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259229 Aug 07, 2017 Sep 07, 2020 View

Package 1

Mandatory forms

293783 RR_SF424_2_0-2.0.pdf

293783 PHS398_CoverPageSupplement_3_0-3.0.pdf

293783 RR_OtherProjectInfo_1_3-1.3.pdf

293783 PerformanceSite_2_0-2.0.pdf

293783 RR_KeyPersonExpanded_2_0-2.0.pdf

293783 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

293783 RR_Budget_1_3-1.3.pdf

293783 RR_SubawardBudget30_1_3-1.3.pdf

293783 PHS398_ModularBudget_1_2-1.2.pdf

293783 PHS_Inclusion_Enrollment_Report-1.0.pdf

293783 PHS_AssignmentRequestForm-1.0.pdf

Package 2

Mandatory forms

293783 RR_SF424_2_0-2.0.pdf

293783 PHS398_CoverPageSupplement_4_0-4.0.pdf

293783 RR_OtherProjectInfo_1_4-1.4.pdf

293783 PerformanceSite_2_0-2.0.pdf

293783 RR_KeyPersonExpanded_2_0-2.0.pdf

293783 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

293783 RR_Budget_1_4-1.4.pdf

293783 RR_SubawardBudget30_1_4-1.4.pdf

293783 PHS398_ModularBudget_1_2-1.2.pdf

293783 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 3

Mandatory forms

293783 RR_SF424_2_0-2.0.pdf

293783 PHS398_CoverPageSupplement_5_0-5.0.pdf

293783 RR_OtherProjectInfo_1_4-1.4.pdf

293783 PerformanceSite_2_0-2.0.pdf

293783 RR_KeyPersonExpanded_2_0-2.0.pdf

293783 PHS398_ResearchPlan_4_0-4.0.pdf

293783 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

293783 RR_Budget_1_4-1.4.pdf

293783 RR_SubawardBudget30_1_4-1.4.pdf

293783 PHS398_ModularBudget_1_2-1.2.pdf

293783 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T09:47:19-05:00

Share This Post, Choose Your Platform!

About the Author: